The ID8 Trp53-/- Brca1-/- model has mutations commonly found in patients with the high-grade serous subtype of ovarian cancer and is highly metastatic as mice injected with cancer cells orthotopically (intrabursal) succumb to disease due to peritoneal dissemination and ascites accumulation (33, 34). This evidence concerns the gene BRCA1 and cancer.